Reports for AMBRISENTAN
Ingredient
AMBRISENTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMBRISENTAN | 5MG | TABLET | Resolved | 2021-05-14 | 2021-06-14 | 139394 |
| APO-AMBRISENTAN | 10MG | TABLET | Resolved | 2021-05-14 | 2021-06-14 | 139397 |
| SANDOZ AMBRISENTAN TABLETS | 5MG | TABLET | Resolved | 2024-01-30 | 2024-04-24 | 217887 |
| SANDOZ AMBRISENTAN TABLETS | 5MG | TABLET | Anticipated shortage | 2025-05-12 | 2025-05-12 | 257070 |
| SANDOZ AMBRISENTAN TABLETS | 10MG | TABLET | Resolved | 2024-02-05 | 2024-04-24 | 218454 |
| SANDOZ AMBRISENTAN TABLETS | 10MG | TABLET | Anticipated shortage | 2025-05-12 | 2025-05-12 | 257067 |
| VOLIBRIS | 10MG | TABLET | Resolved | 2025-02-12 | 2025-02-26 | 250269 |
Showing 1 to 7 of 7
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0